Blockade of endothelial to mesenchymal transition (EndMT) by an inhibitor of histone methyltransferase EZH2 attenuates atherosclerosis in diabetes

Back

ESC2024 Premium Access

Blockade of endothelial to mesenchymal transition (EndMT) by an inhibitor of histone methyltransferase EZH2 attenuates atherosclerosis in diabetes

Session: Targeting endothelial function

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Doctor A. Khan (Melbourne, AU)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Abdul Waheed Khan

Monash University, Melbourne (Australia)

0 follower

8 more presentations in this session

Increased endothelial cell uptake of erythrocyte-derived extracellular vesicles carrying arginase-1 induces endothelial dysfunction in type 2 diabetes

Speaker: Doctor A. Collado (Stockholm, SE)

Access

Abstract

Slides

SMAD3 silencing induces Epithelial-to-Mesenchymal Transition (EMT) towards cardiac pericyte progenitors with proangiogenic potential in hiPSC-derived epicardial cells

Speaker: Doctor Y. Miyoshi (Kyoto, JP)

Inhibition of ketohexokinase prevents fructose-induced insulin resistance and endothelial dysfunction in high fat and sucrose-fed mice via enhancing energy expenditure

Speaker: Doctor H. Viswambharan (Leeds, GB)

Restoration of autophagy reduces diabetes-induced endothelial dysfunction

Speaker: Doctor L. D'Ambrosio (Latina, IT)

Access

Abstract

Slides

STING-mediated DNA damage response in diabetes-induced vascular complications

Speaker: Ms O. Bavuu (Osaka, JP)

Access

Abstract

Slides

Access the full session

Targeting endothelial function

Speakers: Doctor A. Khan, Doctor A. Collado, Doctor Y. Miyoshi, Doctor H. Viswambharan, Doctor L. D'Ambrosio...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources